CH269043A - Process for the preparation of a derivative of the lysergic acid series halogenated on the indole nitrogen. - Google Patents

Process for the preparation of a derivative of the lysergic acid series halogenated on the indole nitrogen.

Info

Publication number
CH269043A
CH269043A CH269043DA CH269043A CH 269043 A CH269043 A CH 269043A CH 269043D A CH269043D A CH 269043DA CH 269043 A CH269043 A CH 269043A
Authority
CH
Switzerland
Prior art keywords
preparation
ergotamine
sep
derivative
acid series
Prior art date
Application number
Other languages
German (de)
Inventor
Ag Sandoz
Original Assignee
Ag Sandoz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ag Sandoz filed Critical Ag Sandoz
Publication of CH269043A publication Critical patent/CH269043A/en

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)

Description

  

  Verfahren zur Darstellung eines am     Indolstickstoff        halogenierten    Derivates  der     Lysergsäure-Reihe.       Das vorliegende Patent betrifft ein Ver  fahren zur Darstellung von     Jod=ergotamin,     welches dadurch gekennzeichnet, ist, dass man  auf     Ergotamin        N-Jod-succinimid    einwirken  lässt.  



  <I>Beispiel:</I>  500 mg am Hochvakuum getrocknetes Er  gotamin werden in 30     cm3        Dioxan    gelöst und  mit, einer Lösung von 260 mg (1,3     Mol)        N-Jod-          succinimid    in 10     cm3        Dioxan    versetzt. Die  orangefarbene Lösung wird noch 15     Minuten     bei Zimmertemperatur gehalten, während wel  cher Zeit sich die Lösung     allmählich    trübt.

    Hierauf     wird    mit 100     cm3    Chloroform ver  setzt, im Schütteltrichter     mit        Sodalösimg    ge  waschen und die an     Natrlllm$lllfat    getrock  nete     Chloroform-Dioxan-Lösung    am     Vakuum          zur    Trockne verdampft. Der Trockenrück  stand wird der     chromatographischen    Tren  nung an 40 g Aluminiumoxyd unterworfen.  



  Bei der Entwicklung des     Chromatogram-          mes    mit absolutem Chloroform gehen nur Spu  ren gelber Nebenprodukte ins Filtrat, wäh  rend das im UV Licht nicht leuchtende     Jod-          ergotamin    erst mit einem Gemisch von     Chloro-          form        mit        1/2        %        Alkohol        ins        Filtrat        gewaschen     wird.

   Es wird so lange mit diesem Lösungs  mittel     eluiert,    bis die etwas stärker an der  Säule haftende, im UV-Licht intensiv violett  leuchtende Zone im Begriffe steht,     ebenfalls     ins Filtrat gewaschen zu werden.    Die auf .diese Weise erhaltenen 260 mg       Jod-ergotamin        kristallisieren        aus        90        %igem     Aceton in gerade abgeschnittenen Platten, die  bei 1740 C     untrer    starker Zersetzung schmelzen  und Kristallösungsmittel enthalten.  



       [a121    des im Hochvakuum bei 1000 ge  trockneten Produktes     -156o    (in Chloroform).  
EMI0001.0048     
  
    Kellersche <SEP> Farbreaktion: <SEP> wie <SEP> Ergotamin.
<tb>  Bruttoformel: <SEP> <B>C"H34väNGJl.</B>
<tb>  ber.: <SEP> C <SEP> 55,99 <SEP> H <SEP> 4,85 <SEP> N <SEP> 9,90%
<tb>  gef.: <SEP> 56,29 <SEP> 5,41 <SEP> 9,92%



  Process for the preparation of a derivative of the lysergic acid series halogenated on the indole nitrogen. The present patent relates to a process for the preparation of iodine = ergotamine, which is characterized in that N-iodosuccinimide is allowed to act on ergotamine.



  <I> Example: </I> 500 mg erotamine dried in a high vacuum are dissolved in 30 cm3 of dioxane and mixed with a solution of 260 mg (1.3 mol) of N-iodosuccinimide in 10 cm3 of dioxane. The orange solution is kept at room temperature for a further 15 minutes, during which time the solution gradually becomes cloudy.

    100 cm3 of chloroform are then added, the mixture is washed with soda solution in a separating funnel and the chloroform-dioxane solution dried on sodium chloride is evaporated to dryness in a vacuum. The dry residue is subjected to chromatographic separation on 40 g of aluminum oxide.



  When developing the chromatogram with absolute chloroform, only traces of yellow by-products go into the filtrate, while the iodineergotamine, which does not glow in UV light, is first washed into the filtrate with a mixture of chloroform with 1/2% alcohol.

   It is eluted with this solvent until the zone, which adheres somewhat more strongly to the column and which is intensely purple in UV light, is about to be washed into the filtrate as well. The 260 mg of iodine-ergotamine obtained in this way crystallize from 90% strength acetone in straight cut plates, which melt at 1740 C with severe decomposition and contain crystal solvents.



       [a121 of the product dried in a high vacuum at 1000 -156o (in chloroform).
EMI0001.0048
  
    Kellersche <SEP> color reaction: <SEP> like <SEP> ergotamine.
<tb> Gross formula: <SEP> <B> C "H34väNGJl. </B>
<tb> ber .: <SEP> C <SEP> 55.99 <SEP> H <SEP> 4.85 <SEP> N <SEP> 9.90%
<tb> found: <SEP> 56.29 <SEP> 5.41 <SEP> 9.92%

 

Claims (1)

PATENTANSPRUCH: Verfahren zur Darstellung von Jod-ergot- amin, dadurch gekennzeichnet, dass man auf Ergotamin N-Jod-succinimid einwirken lässt. Die neue Verbindung besitzt die Brutto formel C"H"0,N,J. Sie kristallisiert aus 90%igem Aceton in gerade abgeschnittenen Platten, die Kristallösungsmittel enthalten und bei 1740C unter Zersetzung schmelzen. PATENT CLAIM: Process for the preparation of iodine-ergotamine, characterized in that N-iodine-succinimide is allowed to act on ergotamine. The new compound has the gross formula C "H" 0, N, J. It crystallizes from 90% acetone in plates that have just been cut off, which contain crystal solvents and which melt at 1740C with decomposition. [a]21 = -1560 (in Chloroform; hoch vakuumtrockenes Präparat). Keller-Reaktion: wie Ergotamin. Die neue Verbindung, das Jod=ergotamin, soll als Zwischenprodukt zur Herstellung von therapeutisch wirksamen Verbindungen Ver wendung finden. [a] 21 = -1560 (in chloroform; highly vacuum-dried preparation). Keller reaction: like ergotamine. The new compound, iodine = ergotamine, is said to be used as an intermediate for the production of therapeutically effective compounds.
CH269043D 1947-07-22 1948-04-29 Process for the preparation of a derivative of the lysergic acid series halogenated on the indole nitrogen. CH269043A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH263279T 1947-07-22
CH269043T 1948-04-29

Publications (1)

Publication Number Publication Date
CH269043A true CH269043A (en) 1950-06-15

Family

ID=25730624

Family Applications (1)

Application Number Title Priority Date Filing Date
CH269043D CH269043A (en) 1947-07-22 1948-04-29 Process for the preparation of a derivative of the lysergic acid series halogenated on the indole nitrogen.

Country Status (1)

Country Link
CH (1) CH269043A (en)

Similar Documents

Publication Publication Date Title
CH269043A (en) Process for the preparation of a derivative of the lysergic acid series halogenated on the indole nitrogen.
US3110711A (en) Process of producing two escin isomers from horse chestnut extracts, and products
DE1770855C3 (en) Process for the preparation of N-trialkylsilyl-6-aminopenicillanic acid trialkylsilyl esters. Eliminated from: 1420981
CH269031A (en) Process for the preparation of a derivative of the lysergic acid series halogenated on the indole nitrogen.
DE2944036C2 (en) Process for the preparation of apovincaminic acid esters
DE4017766A1 (en) New saponin cpds. - obtd. from Gypsophila paniculata and G. arrostii root, for use as pharmaceuticals
CH269044A (en) Process for the preparation of a derivative of the lysergic acid series halogenated on the indole nitrogen.
SU138489A1 (en) The method of obtaining film filters of copper salts
CH269033A (en) Process for the preparation of a derivative of the lysergic acid series halogenated on the indole nitrogen.
CH282602A (en) Process for the preparation of a peptide-like derivative of the lysergic acid series.
US2899449A (en) Phosphatidyl choline compounds
CH269038A (en) Process for the preparation of a derivative of the lysergic acid series halogenated on the indole nitrogen.
CH269042A (en) Process for the preparation of a derivative of the lysergic acid series halogenated on the indole nitrogen.
Eglinton et al. 373. The chemistry of fungi. Part XXXV. A preliminary investigation of ergoflavin
CH269036A (en) Process for the preparation of a derivative of the lysergic acid series halogenated on the indole nitrogen.
AT228409B (en) Process for the production of new lysergic acids
CH282601A (en) Process for the preparation of a peptide-like derivative of the lysergic acid series.
Morice et al. 39. The triterpene group. Part VIII. The minor triterpenoid constituents of Manila elemi resin (continued)
CH269037A (en) Process for the preparation of a derivative of the lysergic acid series halogenated on the indole nitrogen.
CH269039A (en) Process for the preparation of a derivative of the lysergic acid series halogenated on the indole nitrogen.
JPS51125309A (en) Process for preparation of glycerine
CH644860A5 (en) Process for the preparation of apovincamine acid esters
CH269041A (en) Process for the preparation of a derivative of the lysergic acid series halogenated on the indole nitrogen.
CH282611A (en) Process for the preparation of a peptide-like derivative of the lysergic acid series.
ES475512A1 (en) Procedure for the obtaining of 21-esters of corticosteroids from 21-alkilsulfonatos. (Machine-translation by Google Translate, not legally binding)